• Alexander PMA, Di Nardo M, Combes A, et al. Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of an international Delphi process from the ECMO-CENTRAL ARC. Lancet Child Adolesc Health. 2024;8(10):773-780. doi:10.1016/S2352-4642(24)00132-9
• Anselmi A, Guinet P, Ruggieri VG, et al. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 2016;49(1):78-84. doi:10.1093/ejcts/ezv140
• Browder K, Wanek M, Wang L, Hohlfelder B. Opioid and sedative requirements in extracorporeal membrane oxygenation patients on hydromorphone versus fentanyl. Artif Organs. 2022;46(5):878-886.
• Fisser C, Winkler M, Malfertheiner MV, et al. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study. Crit Care. 2021;25(1):160. Published 2021 Apr 29. doi:10.1186/s13054-021-03581-x
• Flanagan T, Mercer K, Johnson PN, Miller J, Yousaf FS, Fuller JA. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. J Pharm Pract. 2024;37(4):985-994.
• Ha MA, Sieg AC. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation. Pharmacotherapy. 2017;37(2):221-235.
• Hamzah M, Seelhammer TG, Beshish AG, et al. Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study. Thromb Res. 2023;229:178-186. doi:10.1016/j.thromres.2023.07.012
• Harthan AA, Buckley KW, Heger ML, Fortuna RS, Mays K. Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther. 2014;19(4):288-295.
• Hynynen M, Hammarén E, Rosenberg PH. Propofol sequestration within the extracorporeal circuit. Can J Anaesth. 1994;41(7):583-588.
• Lemaitre F, Hasni N, Leprince P, et al. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19(1):40. Published 2015 Feb 12.
• Martucci G, Giani M, Schmidt M, et al. Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study. Am J Respir Crit Care Med. 2024;209(4):417-426. doi:10.1164/rccm.202305-0896OC
• Mayerhöfer T, Joannidis M, Peer A, et al. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study. Thromb Res. 2024;236:161-166. doi:10.1016/j.thromres.2024.02.026
• Mazzeffi M, Bathula A, Tabatabai A, et al. Von Willebrand Factor Concentrate Administration for Acquired Von Willebrand Syndrome- Related Bleeding During Adult Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth. 2021;35(3):882-887. doi:10.1053/j.jvca.2020.06.083
• McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO Adult and Pediatric Anticoagulation Guidelines. ASAIO J. 2022;68(3):303-310. doi:10.1097/MAT.0000000000001652
• Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736-2747. doi:10.1161/CIRCULATIONAHA.110.009449
• Repessé X, Au SM, Bréchot N, et al. Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review. Crit Care. 2013;17(2):R55. Published 2013 Mar 25. doi:10.1186/cc12581
• Seelhammer TG, Bohman JK, Schulte PJ, Hanson AC, Aganga DO. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation. Crit Care Med. 2021;49(9):1481-1492. doi:10.1097/CCM.0000000000005033
• Shekar K, Roberts JA, Mcdonald CI, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012;16(5):R194. Published 2012 Oct 15.
• Zarfoss EL, Garavaglia J, Hayanga JWA, Kabulski G. Comparison of Standard-Dose Versus High-Dose Dexmedetomidine in Extracorporeal Membrane Oxygenation. Ann Pharmacother. 2023;57(2):121-126.